People wear face masks at a temporary outdoor food market in New York City. (Photo by Noam Galai/Getty Images)RELATED: Coronavirus-related face masks protect the wearer, too: CDC says in updated guidanceThe company reported that its trial candidates experienced mild and short side effects but didn’t elaborate on the symptoms in an issued press release.
Safety followups will continue.Medicago researchers selected 180 men and women between 18 and 55 years old for the trial. The company hopes to get government approval to enter Phase 2 and then 3 of the trial.Advertisement"The positive results of our Phase 1 clinical trial are a step forward in the fight against the COVID-19 pandemic," said Dr.